Biomarin Pharmaceutical Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 138.7 | 182.3 | 17.7 | 18.8 | 17.5 | 18.5 | 889.8 | – | 381.9 | 287.4 | 187.6 | 136.0 | 263.8 | 169.1 | 115.1 | 110.3 | 84.7 | 64.3 | 43.0 | 30.3 | 26.5 | 16.5 | 20.0 | 33.6 | 41.6 | 152.2 | |
| 14.8 | 12.8 | 12.8 | 13.2 | 13.0 | 11.9 | 10.3 | 11.6 | 11.5 | 10.2 | 10.4 | 10.0 | 7.8 | 9.1 | 8.8 | 12.1 | 8.1 | 8.7 | 7.5 | 8.1 | 7.7 | 8.8 | 8.0 | 8.1 | 7.8 | 9.2 | 8.7 | 7.6 | 7.3 | 7.6 | 7.0 | 6.4 | 5.0 | 4.5 | 4.7 | 3.5 | 3.4 | 3.6 | 3.4 | 3.3 | |
| 5.9 | 5.2 | 5.5 | 5.7 | 5.8 | 5.6 | 5.1 | 5.8 | 5.9 | 5.1 | 5.4 | 5.2 | 4.1 | 4.9 | 4.9 | 6.9 | 3.7 | 3.9 | 3.3 | 3.6 | 3.3 | 3.8 | 3.4 | 3.4 | 3.4 | 4.2 | 4.1 | 3.5 | 3.5 | 3.7 | 3.4 | 3.1 | 2.6 | 2.3 | 2.4 | 1.8 | 1.7 | 1.9 | 1.8 | 1.8 | |
| 14.8 | 13.0 | 13.1 | 14.0 | 13.6 | 12.4 | 10.8 | 12.1 | 11.7 | 10.4 | 10.7 | 10.4 | 8.1 | 9.3 | 9.0 | 12.4 | 8.3 | 8.9 | 7.8 | 8.3 | 7.9 | 9.1 | 8.3 | 8.4 | 8.0 | 9.4 | 8.9 | 7.7 | 7.5 | 7.8 | 7.2 | 6.4 | 5.0 | 4.4 | 4.6 | 3.3 | 3.2 | 3.4 | 3.2 | 4.2 | |
| – | – | – | – | – | 178.6 | 214.2 | 192.9 | 177.9 | – | – | – | – | 481.4 | 84.8 | 120.2 | 126.8 | 181.3 | 1,154.5 | 236.9 | 190.8 | 352.7 | 98.3 | 90.7 | 73.2 | 73.5 | 103.0 | 77.1 | 64.3 | 60.8 | 49.4 | 39.5 | 27.2 | 19.3 | 17.3 | 10.9 | 12.6 | 19.2 | 21.5 | 37.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,023.5 | – | 132.9 | 90.6 | 79.7 | 85.9 | 544.4 | – | 386.2 | 434.0 | 867.8 | 413.2 | 540.7 | 358.1 | 106.6 | 77.5 | 46.1 | 27.2 | 22.4 | 15.6 | 12.6 | 16.3 | 14.7 | 15.2 | |
| -3.2% | -2.6% | -2.0% | -1.7% | -1.4% | -1.3% | -0.9% | -1.0% | -0.9% | -0.8% | -0.9% | -0.9% | -0.8% | -0.7% | -0.5% | -0.1% | 0.1% | -0.2% | 0.8% | 1.1% | 1.3% | 1.2% | 0.2% | 0.0% | 0.3% | 0.2% | 0.1% | 0.2% | 0.2% | 0.3% | 0.9% | 1.3% | 2.2% | 3.7% | 4.5% | 6.4% | 7.9% | 6.1% | 6.8% | 6.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 82.0% | 81.2% | 81.7% | 81.6% | 81.7% | 81.6% | 80.2% | 79.4% | 78.9% | 78.9% | 78.8% | 79.1% | 78.9% | 78.9% | 78.9% | 78.2% | 73.5% | 71.8% | 71.1% | 70.7% | 74.2% | 74.5% | 75.1% | 75.8% | 76.3% | 76.9% | 76.9% | 77.2% | 77.4% | 78.1% | 79.0% | 79.9% | 78.9% | 79.7% | 79.4% | 79.6% | 81.3% | 77.1% | 75.9% | 75.5% | |
| -58.6% | -71.9% | -62.7% | -17.4% | -12.9% | -1.1% | -2.8% | -1.8% | -1.8% | -8.3% | -8.8% | -9.7% | -8.1% | -5.9% | 3.2% | 3.2% | -0.1% | -2.0% | -6.3% | -3.3% | -3.3% | -4.5% | 1.6% | 3.0% | 5.4% | 7.1% | 3.4% | 4.5% | 5.8% | 7.1% | 8.0% | 9.8% | 12.2% | 17.0% | 21.0% | 25.3% | 19.9% | 16.6% | 13.5% | 8.0% | |
| -45.1% | -55.4% | -46.6% | -14.1% | -11.5% | -8.9% | -10.5% | -8.7% | -8.4% | -5.2% | -5.9% | -7.2% | -2.7% | -1.4% | 6.3% | 6.6% | 45.7% | 46.2% | 43.1% | 43.7% | 0.9% | -3.5% | 2.1% | 2.8% | 4.2% | 6.8% | 3.3% | 4.5% | 6.4% | 6.9% | 8.3% | 9.9% | 11.7% | 15.0% | 17.8% | 21.5% | 16.8% | 10.8% | 8.3% | 2.1% | |
| -47.6% | -33.7% | -26.1% | -22.2% | -18.6% | -15.8% | -9.5% | -11.0% | -10.5% | -8.3% | -8.9% | -9.2% | -6.5% | -6.2% | -4.3% | -1.1% | 0.8% | -1.9% | 5.7% | 8.9% | 9.6% | 10.2% | 1.5% | -0.2% | 2.0% | 2.1% | 1.0% | 1.8% | 1.4% | 2.1% | 6.6% | 8.2% | 10.9% | 16.7% | 21.0% | 22.6% | 26.7% | 22.3% | 23.5% | 21.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -17.8% | -22.3% | -19.9% | -6.1% | -5.1% | -4.2% | -5.2% | -4.3% | -4.3% | -2.6% | -3.0% | -3.7% | -1.4% | -0.8% | 3.5% | 3.8% | 21.0% | 20.9% | 19.1% | 19.7% | 0.4% | -1.5% | 0.9% | 1.2% | 1.8% | 3.1% | 1.5% | 2.1% | 3.0% | 3.4% | 4.0% | 4.9% | 6.0% | 7.5% | 9.0% | 10.9% | 8.6% | 5.7% | 4.3% | 1.2% | |
| -12.3% | -15.4% | -14.0% | -4.2% | -3.2% | -2.5% | -3.2% | -2.7% | -2.7% | -1.7% | -2.0% | -2.5% | -0.9% | -0.5% | 2.4% | 2.3% | 13.8% | 14.7% | 13.7% | 14.2% | 0.3% | -1.1% | 0.6% | 0.9% | 1.3% | 2.2% | 1.1% | 1.5% | 2.2% | 2.5% | 3.0% | 3.6% | 4.7% | 6.1% | 7.3% | 8.8% | 6.8% | 4.6% | 3.1% | 0.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -32 | 275 | 343 | 998 | 752 | 576 | 709 | 764 | 318 | 336 | 480 | 542 | 431 | 421 | 386 | 636 | 444 | 438 | 420 | 447 | 471 | 502 | 485 | 472 | 330 | 369 | 513 | 399 | 310 | 341 | 350 | 127 | -73 | -340 | -447 | -610 | -646 | -706 | -783 | 3,328 | |
| – | – | – | – | – | 6.3 | 10.1 | 8.5 | 3.2 | – | – | – | – | 12.8 | 2.0 | 3.3 | 3.6 | 4.8 | 33.8 | 6.7 | 6.1 | 10.6 | 3.1 | 2.7 | 1.5 | 1.4 | 2.7 | 1.8 | 1.2 | 1.1 | 1.0 | 0.3 | -0.1 | -0.5 | -0.6 | -0.7 | -0.8 | -1.2 | -1.6 | 8.6 | |
| 68.9% | 68.7% | 70.3% | 69.5% | 61.4% | 60.6% | 61.1% | 62.4% | 62.1% | 67.0% | 66.2% | 67.4% | 67.4% | 66.6% | 68.6% | 61.0% | 65.8% | 70.2% | 71.7% | 71.9% | 71.4% | 71.1% | 72.4% | 73.3% | 72.9% | 72.2% | 72.4% | 72.9% | 72.5% | 72.4% | 73.8% | 74.8% | 79.0% | 81.0% | 81.1% | 80.8% | 79.5% | 80.2% | 72.3% | 53.9% | |
| 0.3 | 0.2 | 0.2 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.81 | -3.59 | -3.19 | -0.97 | -0.82 | -0.67 | -0.82 | -0.71 | -0.70 | -0.43 | -0.50 | -0.62 | -0.23 | -0.13 | 0.61 | 0.68 | 4.31 | 4.66 | 4.31 | 4.52 | 0.09 | -0.35 | 0.20 | 0.29 | 0.45 | 0.76 | 0.37 | 0.51 | 0.77 | 0.87 | 1.03 | 1.28 | 1.63 | 2.17 | 2.67 | 3.34 | 2.71 | 1.77 | 1.36 | 0.38 | |
| 6.23 | 6.48 | 6.85 | 6.89 | 7.17 | 7.48 | 7.85 | 8.13 | 8.43 | 8.37 | 8.52 | 8.56 | 8.62 | 9.34 | 9.65 | 10.22 | 9.42 | 10.08 | 10.00 | 10.34 | 10.09 | 10.06 | 9.64 | 10.20 | 10.82 | 11.27 | 11.18 | 11.46 | 12.09 | 12.61 | 12.40 | 12.91 | 13.96 | 14.52 | 15.02 | 15.58 | 16.11 | 16.32 | 16.40 | 17.55 | |
| 15.78 | 16.06 | 16.03 | 16.03 | 16.07 | 15.99 | 15.94 | 16.31 | 16.42 | 16.66 | 16.47 | 16.54 | 16.54 | 17.12 | 17.31 | 17.91 | 20.51 | 22.26 | 22.57 | 22.87 | 23.29 | 23.27 | 22.53 | 24.03 | 24.62 | 24.74 | 23.97 | 24.53 | 25.62 | 25.81 | 25.46 | 26.36 | 27.46 | 28.78 | 29.49 | 30.65 | 31.54 | 30.84 | 31.43 | 32.56 | |
| -2.96 | -2.18 | -1.79 | -1.53 | -1.34 | -1.18 | -0.74 | -0.90 | -0.88 | -0.70 | -0.76 | -0.79 | -0.56 | -0.58 | -0.41 | -0.11 | 0.07 | -0.20 | 0.57 | 0.92 | 0.97 | 1.03 | 0.14 | -0.02 | 0.22 | 0.24 | 0.11 | 0.21 | 0.16 | 0.27 | 0.82 | 1.06 | 1.53 | 2.42 | 3.16 | 3.52 | 4.30 | 3.65 | 3.85 | 3.77 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.